United States · FDA National Drug Code directory
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42385-928_27623aed-629d-4406-a0bf-4f234fc4e6c6
- Product NDC
- 42385-928
- Form
- TABLET, FILM COATED
- Composition / generic term
- Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- Labeler
- Laurus Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200514
- Source listing expiry
- 20261231
Source-listed ingredients
- EFAVIRENZ — 600 mg/1
- LAMIVUDINE — 300 mg/1
- TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (42385-928-30) · 42385-928-30
- 90 TABLET, FILM COATED in 1 BOTTLE (42385-928-90) · 42385-928-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →